| Home : Cytovation and SMS-oncology Sign Agreement on Conduct of Phase I/II Trial With CyPep-1 in Solid Tumors |
|
Aug 09
2019 |
Cytovation and SMS-oncology Sign Agreement on Conduct of Phase I/II Trial With CyPep-1 in Solid Tumors |
|
BERGEN, Norway and SCHIPHOL, The Netherlands, Aug. 9, 2019 /PRNewswire/ -- Cytovation AS ("Cytovation") and Specialized Medical Services-oncology BV ("SMS-oncology") today announce that SMS-oncology has been selected as the CRO to conduct the phase I/II clinical trial with CyPep-1 in... |
|
|
|
| Source:https://www.prnewswire.com:443/news-releases/cytovation-and-sms-oncology-sign-agreement-on-conduct-of-phase-iii-trial-with-cypep-1-in-solid-tumors-300899333.html |
| |
|
Related News
|
» Meet the Top 10 Entrepreneurs and Their Companies to Look Out for in 2019
» Starkes Wachstum von MLP Care setzte sich im zweiten Quartal von 2019 fort
|
